Elizabeth P. Garner

Learn More
This Phase 2 study evaluated the safety and efficacy of elagolix for treating endometriosis-associated pain. A total of 155 women with laparoscopically confirmed endometriosis were randomized to placebo, elagolix 150 mg, or elagolix 250 mg once daily for 12 weeks. Placebo patients were rerandomized to elagolix and elagolix patients continued their dosing(More)
This randomized double-blind study, with 24-week treatment and 24-week posttreatment periods, evaluated the effects of elagolix (150 mg every day, 75 mg twice a day) versus subcutaneous depot medroxyprogesterone acetate (DMPA-SC) on bone mineral density (BMD), in women with endometriosis-associated pain (n = 252). All treatments induced minimal mean changes(More)
diagnostic skin tests. All parasites may not necessarily produce as intense or as long-lasting an immediate hypersensitivity as does T. canis (Wiseman and Woodruff, 1970), and any trial of an antigen in subjects with different known infections should preferably include a direct comparison with their response to homologous antigen. This sesponse cannot be(More)
It was hypothesized white-tailed deer {Odocoileus virginianus) could be readily conditioned to 2 commonly used deterrents, Deer-Away® Big Game Repellent (BGR) and blood meal (BM). Plots were randomly assigned BGR, BM and control. Free-ranging deer were initially conditioned to forage for corn at each 49m bare earth plots delivered at 0500 hr and 1600 hr by(More)
The frequency of hemorrhagic disturbance was calculated retrospectively among 207 sterilized women prior to and after sterilization. Significantly more women experienced metrorrhagia requiring curettage in the 7-year period after sterilization than during the 7-year period prior to it. 75 patients who were sterilized between the ages of 27-30 years were(More)
  • 1